Literature DB >> 9596745

Neither the Bvg- phase nor the vrg6 locus of Bordetella pertussis is required for respiratory infection in mice.

G Martinez de Tejada1, P A Cotter, U Heininger, A Camilli, B J Akerley, J J Mekalanos, J F Miller.   

Abstract

In Bordetella species, the BvgAS sensory transduction system mediates an alteration between the Bvg+ phase, characterized by expression of adhesins and toxins, and the Bvg- phase, characterized by the expression of motility and coregulated phenotypes in Bordetella bronchiseptica and by the expression of vrg loci in Bordetella pertussis. Since there is no known environmental or animal reservoir for B. pertussis, the causative agent of whooping cough, it has been assumed that this phenotypic alteration must occur within the human host during infection. Consistent with this hypothesis was the observation that a B. pertussis mutant, SK6, containing a TnphoA insertion mutation in a Bvg-repressed gene (vrg6) was defective for tracheal and lung colonization in a mouse model of respiratory infection (D. T. Beattie, R. Shahin, and J. Mekalanos, Infect. Immun. 60:571-577, 1992). This result was inconsistent, however, with the observation that a Bvg+ phase-locked B. bronchiseptica mutant was indistinguishable from the wild type in its ability to establish a persistent respiratory infection in rabbits and rats (P. A. Cotter and J. F. Miller, Infect. Immun. 62:3381-3390, 1994; B. J. Akerley, P. A. Cotter, and J. F. Miller, Cell 80:611-620, 1995). To directly address the role of Bvg-mediated signal transduction in B. pertussis pathogenesis, we constructed Bvg+ and Bvg- phase-locked mutants and compared them with the wild type for their ability to colonize the respiratory tracts of mice. Our results show that the Bvg+ phase of B. pertussis is necessary and sufficient for respiratory infection. By constructing a strain with a deletion in the bvgR regulatory locus, we also show that ectopic expression of Bvg- phase phenotypes decreases the efficiency of colonization, underscoring the importance of Bvg-mediated repression of gene expression in vivo. Finally, we show that the virulence defect present in strain SK6 cannot be attributed to the vrg6 mutation. These data contradict an in vivo role for the Bvg- phase of B. pertussis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9596745      PMCID: PMC108267          DOI: 10.1128/IAI.66.6.2762-2768.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Antigenic modulation of Bordetella pertussis.

Authors:  B W LACEY
Journal:  J Hyg (Lond)       Date:  1960-03

2.  Lethal infection by Bordetella pertussis mutants in the infant mouse model.

Authors:  A A Weiss; M S Goodwin
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

3.  Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes.

Authors:  B Aricò; R Rappuoli
Journal:  J Bacteriol       Date:  1987-06       Impact factor: 3.490

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Two trans-acting regulatory genes (vir and mod) control antigenic modulation in Bordetella pertussis.

Authors:  S Knapp; J J Mekalanos
Journal:  J Bacteriol       Date:  1988-11       Impact factor: 3.490

6.  Tn5-induced mutations affecting virulence factors of Bordetella pertussis.

Authors:  A A Weiss; E L Hewlett; G A Myers; S Falkow
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

Review 7.  Biology of Bordetella bronchiseptica.

Authors:  R A Goodnow
Journal:  Microbiol Rev       Date:  1980-12

8.  Mutations that alter the signal sequence of alkaline phosphatase in Escherichia coli.

Authors:  S Michaelis; H Inouye; D Oliver; J Beckwith
Journal:  J Bacteriol       Date:  1983-04       Impact factor: 3.490

9.  Genetic diversity and relationships in populations of Bordetella spp.

Authors:  J M Musser; E L Hewlett; M S Peppler; R K Selander
Journal:  J Bacteriol       Date:  1986-04       Impact factor: 3.490

10.  Heptakis(2,6-O-dimethyl)beta-cyclodextrin: a novel growth stimulant for Bordetella pertussis phase I.

Authors:  A Imaizumi; Y Suzuki; S Ono; H Sato; Y Sato
Journal:  J Clin Microbiol       Date:  1983-05       Impact factor: 5.948

View more
  43 in total

1.  Differential regulation of Bvg-activated virulence factors plays a role in Bordetella pertussis pathogenicity.

Authors:  S M Kinnear; R R Marques; N H Carbonetti
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  New virulence-activated and virulence-repressed genes identified by systematic gene inactivation and generation of transcriptional fusions in Bordetella pertussis.

Authors:  R Antoine; S Alonso; D Raze; L Coutte; S Lesjean; E Willery; C Locht; F Jacob-Dubuisson
Journal:  J Bacteriol       Date:  2000-10       Impact factor: 3.490

Review 3.  Bordetella pertussis transmission.

Authors:  Elizabeth A Trainor; Tracy L Nicholson; Tod J Merkel
Journal:  Pathog Dis       Date:  2015-09-14       Impact factor: 3.166

4.  Bordetella bronchiseptica adherence to cilia is mediated by multiple adhesin factors and blocked by surfactant protein A.

Authors:  Jessica A Edwards; Nathan A Groathouse; Scott Boitano
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

Review 5.  Two-component signal transduction systems, environmental signals, and virulence.

Authors:  E Calva; R Oropeza
Journal:  Microb Ecol       Date:  2006-01-31       Impact factor: 4.552

6.  Microarray and functional analysis of growth phase-dependent gene regulation in Bordetella bronchiseptica.

Authors:  Tracy L Nicholson; Anne M Buboltz; Eric T Harvill; Susan L Brockmeier
Journal:  Infect Immun       Date:  2009-08-10       Impact factor: 3.441

7.  An improved recombination-based in vivo expression technology-like reporter system reveals differential cyaA gene activation in Bordetella species.

Authors:  Matthew S Byrd; Eliza Mason; Michael W Henderson; Erich V Scheller; Peggy A Cotter
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

8.  Characterization of a highly conserved island in the otherwise divergent Bordetella holmesii and Bordetella pertussis genomes.

Authors:  D A Diavatopoulos; C A Cummings; H G J van der Heide; M van Gent; S Liew; D A Relman; F R Mooi
Journal:  J Bacteriol       Date:  2006-10-13       Impact factor: 3.490

9.  Strain-dependent role of BrkA during Bordetella pertussis infection of the murine respiratory tract.

Authors:  Kelly D Elder; Eric T Harvill
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

10.  Cavitary pneumonia in an AIDS patient caused by an unusual Bordetella bronchiseptica variant producing reduced amounts of pertactin and other major antigens.

Authors:  Benito Lorenzo-Pajuelo; José Luis Villanueva; Juan Rodríguez-Cuesta; Nuria Vergara-Irigaray; Máximo Bernabeu-Wittel; Andrés Garcia-Curiel; Guillermo Martínez de Tejada
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.